Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 117Triple Negative Breast Neoplasms 45Neoplasm Metastasis 11Pancreatic Neoplasms 8Inflammatory Breast Neoplasms 7Breast Neoplasms, Male 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 4Neoplasms 4Lung Neoplasms 4Carcinoma, Ductal, Breast 4Sarcoma 3Prostatic Neoplasms 3Lymphoma, Non-Hodgkin 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Hodgkin Disease 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Advanced Breast Cancer 2Thrombocytosis 1Stages II-III Breast Cancer 1Primary Myelofibrosis 1

Interventions

Fulvestrant 19Letrozole 10Anastrozole 8Capecitabine 5palbociclib 4olaparib 4Paclitaxel 4Injections 4Goserelin 4Docetaxel 4trastuzumab deruxtecan 3pyrotinib 3exemestane 3Vinorelbine 3Aromatase Inhibitors 3toripalimab 2sacituzumab govitecan 2ribociclib 2eribulin 2elacestrant 2dalpiciclib 2abemaciclib 2Trastuzumab 2Gonadotropin-Releasing Hormone 2FCN-437c 2Everolimus 2Dasatinib 2Alpelisib 2Albumin-Bound Paclitaxel 2AZD9833 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Breast Cancer × Albumin-Bound Paclitaxel × Breast × Clear all
NCT04826016 2023-03-20

POLTER

MedSIR

Phase 1/2 Withdrawn
Breast

Advanced Breast Cancer

NCT05274893 2022-03-11

A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer

CSPC Ouyi Pharmaceutical Co., Ltd.

Phase 1 Unknown
28 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡